
Health Catalyst Capital is a private equity and venture capital firm that specializes in growth-stage investments within the U.S. healthcare information technology and tech-enabled services sectors. The firm focuses on scaling digital health platforms, AI-driven diagnostics, and value-based care models to enhance care quality, access, and affordability.
94% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Their most common stage is series-b (44% of deals). Average disclosed round size is $36.2M (across 13 rounds with reported amounts).
Portfolio
16
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Growth | $75M | Oct 2025 | |
| Series A | — | Feb 2025 | |
| BBrixton Biosciences | Series B | $33M | May 2024 |
| Growth | $56.5M | Apr 2024 | |
| Series B | $31M | Sep 2023 | |
| Series B | $25M | Dec 2022 | |
| Series C | $70M | Sep 2021 | |
| Series A | $12M | Feb 2021 | |
| Series C | $85M | Aug 2020 | |
| Series B | $9M | Dec 2018 | |
| Growth | — | Nov 2016 | |
| MMaxwell Health | Series B | $26.4M | Dec 2014 |
| LLantos Technologies | Series B | $4.1M | Aug 2011 |
| Unknown | — | — | |
| HHolmusk | Series A | $21.5M | — |
| Series B | $22M | — |
Top Co-Investors
Schooner Capital2 shared
Spartan Group2 shared
Lux Capital2 shared
Laerdal Million Lives Fund1 shared
Blue Venture Fund1 shared
Blue Heron Capital1 shared
Revolution's Rise of the Rest Fund1 shared
SV Health Investors1 shared
Broadview Ventures1 shared
Felicis Ventures1 shared
First Round Capital1 shared
Uncork Capital1 shared
Indicator Ventures1 shared
RTP Global1 shared
Human Ventures1 shared
Mercato Partners1 shared
7wireVentures1 shared
Distributed Ventures1 shared
Semper Virens1 shared
Last updated: 24 April 2026